Table of Contents Author Guidelines Submit a Manuscript
Journal of Toxicology
Volume 2016, Article ID 9794570, 7 pages
http://dx.doi.org/10.1155/2016/9794570
Research Article

Evaluation of “Dream Herb,” Calea zacatechichi, for Nephrotoxicity Using Human Kidney Proximal Tubule Cells

Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), US Food and Drug Administration (US FDA), Neurotoxicology and In Vitro Toxicology Branch (NIVTB), 8301 Muirkirk Road, Laurel, MD 20708, USA

Received 29 February 2016; Accepted 1 August 2016

Academic Editor: Orish Ebere Orisakwe

Copyright © 2016 Miriam E. Mossoba et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Díaz, “Ethnopharmacology and taxonomy of Mexican psychodysleptic plants,” Journal of Psychedelic Drugs, vol. 11, no. 1-2, pp. 71–101, 1979. View at Publisher · View at Google Scholar · View at Scopus
  2. S. O’Mahony Carey, “Psychoactive substances: a guide to ethnobotanical plants and herbs, synthetic chemicals, compounds and products,” 2010.
  3. R. Román-Ramos, J. L. Flores-Sáenz, G. Partida-Hernandez, A. Lara-Lemus, and F. Alarcon-Aguilar, “Experimental study of the hypoglycemic effect of some antidiabetic plants,” Archivos de Investigacion Medica, vol. 22, no. 1, pp. 87–93, 1991. View at Google Scholar · View at Scopus
  4. F. J. Alarcon-Aguilara, R. Roman-Ramos, S. Perez-Gutierrez, A. Aguilar-Contreras, C. C. Contreras-Weber, and J. L. Flores-Saenz, “Study of the anti-hyperglycemic effect of plants used as antidiabetics,” Journal of Ethnopharmacology, vol. 61, no. 2, pp. 101–110, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Andrade-Cetto and M. Heinrich, “Mexican plants with hypoglycaemic effect used in the treatment of diabetes,” Journal of Ethnopharmacology, vol. 99, no. 3, pp. 325–348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. I.-Y. Lee, F. R. Fronczek, A. Malcolm, N. H. Fischer, and L. E. Urbatsch, “New germacranolides from Calea ternifolia and the molecular structure of 9α-hydroxy-11,13-dihydro-11α,13-epoxyatripliciolide-8β-o-[2- methylacrylate],” Journal of Natural Products, vol. 45, no. 3, pp. 311–316, 1982. View at Publisher · View at Google Scholar · View at Scopus
  7. N. H. Fischer, I.-Y. Lee, F. R. Fronczek, G. Chiari, and L. E. Urbatsch, “Three new furanone-type heliangolides from Calea ternifolia and the molecular structure of 8β-angeloyloxy-9α-hydroxycalyculatolide,” Journal of Natural Products, vol. 47, no. 3, pp. 419–425, 1984. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Wu, F. R. Fronczek, C. L. Burandt, and J. K. Zjawiony, “Antileishmanial germacranolides from Calea zacatechichi,” Planta Medica, vol. 77, no. 7, pp. 749–753, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. V. Mariano, S. F. Antonio, and P. Joseph-Nathan, “Thymol derivatives from Calea nelsonii,” Phytochemistry, vol. 26, no. 9, pp. 2577–2579, 1987. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Cuatrecasas, “Prima flora colombiana: 3. Compositae—astereae,” Webbia, vol. 24, no. 1, pp. 1–335, 1969. View at Publisher · View at Google Scholar
  11. Y. J. Moon, X. Wang, and M. E. Morris, “Dietary flavonoids: effects on xenobiotic and carcinogen metabolism,” Toxicology in Vitro, vol. 20, no. 2, pp. 187–210, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Ren, Z. Qiao, H. Wang, L. Zhu, and L. Zhang, “Flavonoids: promising anticancer agents,” Medicinal Research Reviews, vol. 23, no. 4, pp. 519–534, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Hodek, P. Trefil, and M. Stiborová, “Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450,” Chemico-Biological Interactions, vol. 139, no. 1, pp. 1–21, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Merfort, “Perspectives on sesquiterpene lactones in inflammation and cancer,” Current Drug Targets, vol. 12, no. 11, pp. 1560–1573, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Ghantous, H. Gali-Muhtasib, H. Vuorela, N. A. Saliba, and N. Darwiche, “What made sesquiterpene lactones reach cancer clinical trials?” Drug Discovery Today, vol. 15, no. 15-16, pp. 668–678, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. K. Chahar, N. Sharma, M. P. Dobhal, and Y. C. Joshi, “Flavonoids: a versatile source of anticancer drugs,” Pharmacognosy Reviews, vol. 5, no. 9, pp. 1–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Klaassen, Casarett & Doull's Toxicology: The Basic Science of Poisons, McGraw-Hill Professional, 8th edition, 2013.
  18. Y. S. Kanwar, J. Wada, L. Sun et al., “Diabetic nephropathy: mechanisms of renal disease progression,” Experimental Biology and Medicine, vol. 233, no. 1, pp. 4–11, 2008. View at Publisher · View at Google Scholar
  19. S. P. Bagby, “Diabetic nephropathy and proximal tubule ROS: challenging our glomerulocentricity,” Kidney International, vol. 71, no. 12, pp. 1199–1202, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Vallon, “The proximal tubule in the pathophysiology of the diabetic kidney,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 300, no. 5, pp. R1009–R1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Wu, D. Connors, L. Barber, S. Jayachandra, U. M. Hanumegowda, and S. P. Adams, “Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compounds,” Toxicology in Vitro, vol. 23, no. 6, pp. 1170–1178, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-J. Sohn, S. Y. Kim, H. S. Kim et al., “In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells,” Toxicology Letters, vol. 217, no. 3, pp. 235–242, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Gunness, K. Aleksa, K. Kosuge, S. Ito, and G. Koren, “Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity,” Canadian Journal of Physiology and Pharmacology, vol. 88, no. 4, pp. 448–455, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Jennings, S. Aydin, J. Bennett et al., “Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustion,” Toxicology in Vitro, vol. 23, no. 3, pp. 486–499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. N. D. Keirstead, M. P. Wagoner, P. Bentley et al., “Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers,” Toxicological Sciences, vol. 137, no. 2, Article ID kft247, pp. 278–291, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Dieterle, F. Sistare, F. Goodsaid et al., “Renal biomarker qualification submission: a dialog between the FDA-EMEA and predictive safety testing consortium,” Nature Biotechnology, vol. 28, no. 5, pp. 455–462, 2010. View at Publisher · View at Google Scholar
  27. D. Eisinger, “Better tools for screening: early biomarkers of kidney toxicity,” Drug Discovery & Development, vol. 16, no. 5, pp. 16–20, 2013. View at Google Scholar
  28. J. V. Bonventre, V. S. Vaidya, R. Schmouder, P. Feig, and F. Dieterle, “Next-generation biomarkers for detecting kidney toxicity,” Nature Biotechnology, vol. 28, no. 5, pp. 436–440, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. E. Mossoba, T. J. Flynn, S. Vohra, P. L. Wiesenfeld, and R. L. Sprando, “Human kidney proximal tubule cells are vulnerable to the effects of Rauwolfia serpentina,” Cell Biology and Toxicology, vol. 31, no. 6, pp. 285–293, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Bohlmann and C. Zdero, “Neue germacrolide aus Calea zacatechichi,” Phytochemistry, vol. 16, no. 7, pp. 1065–1068, 1977. View at Publisher · View at Google Scholar · View at Scopus
  31. P. K. Chowdhury, R. P. Sharma, G. Thyagarajan, W. Herz, and S. V. Govindan, “Stereochemisty of ciliarin, zexbrevin, and their relatives,” Journal of Organic Chemistry, vol. 45, no. 24, pp. 4993–4997, 1980. View at Publisher · View at Google Scholar · View at Scopus
  32. W. Herz and N. Kumar, “Sesquiterpene lactones of Calea zacatechichi and C. urticifolia,” Phytochemistry, vol. 19, no. 4, pp. 593–597, 1980. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Köhler, K. Jenett-Siems, K. Siems et al., “In vitro antiplasmodial investigation of medicinal plants from El Salvador,” Zeitschrift für Naturforschung C, vol. 57, no. 3-4, pp. 277–281, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. Louisiana, S. o. Louisiana Board of Pharmacy, Laws and Regulations (40) L. Legislature. Section 989.1, C. (3) (kk), April 2013.
  35. K. Simonienko, N. Waszkiewicz, and A. Szulc, “Psychoactive plant species—actual list of plants prohibited in Poland,” Psychiatria Polska, vol. 47, no. 3, pp. 499–510, 2013. View at Google Scholar
  36. F. Zucco, I. De Angelis, E. Testai, and A. Stammati, “Toxicology investigations with cell culture systems: 20 Years after,” Toxicology in Vitro, vol. 18, no. 2, pp. 153–163, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. C. L. Broadhead and R. D. Combes, “The current status of food additives toxicity testing and the potential for application of the three Rs,” ATLA Alternatives to Laboratory Animals, vol. 29, no. 4, pp. 471–485, 2001. View at Google Scholar · View at Scopus
  38. M. A. Perazella, “Renal vulnerability to drug toxicity,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 7, pp. 1275–1283, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Schetz, J. Dasta, S. Goldstein, and T. Golper, “Drug-induced acute kidney injury,” Current Opinion in Critical Care, vol. 11, no. 6, pp. 555–565, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. R. C. Harris and E. G. Neilson, “Toward a unified theory of renal progression,” Annual Review of Medicine, vol. 57, pp. 365–380, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. M. J. Ryan, G. Johnson, J. Kirk, S. M. Fuerstenberg, R. A. Zager, and B. Torok-Storb, “HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney,” Kidney International, vol. 45, no. 1, pp. 48–57, 1994. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Vlasakova, Z. Erdos, S. P. Troth et al., “Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies,” Toxicological Sciences, vol. 138, no. 1, pp. 3–20, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Venegas-Flores, D. Segura-Cobos, and B. Vázquez-Cruz, “Antiinflammatory activity of the aqueous extract of Calea zacatechichi,” Proceedings of the Western Pharmacology Society, vol. 45, pp. 110–111, 2002. View at Google Scholar · View at Scopus
  44. L. Mayagoitia, J.-L. Díaz, and C. M. Contreras, “Psychopharmacologic analysis of an alleged oneirogenic plant: Calea zacatechichi,” Journal of Ethnopharmacology, vol. 18, no. 3, pp. 229–243, 1986. View at Publisher · View at Google Scholar · View at Scopus
  45. M. J. Lenardo and D. Baltimore, “NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control,” Cell, vol. 58, no. 2, pp. 227–229, 1989. View at Publisher · View at Google Scholar · View at Scopus
  46. Z. Sun and R. Andersson, “NF-κB activation and inhibition: a review,” Shock, vol. 18, no. 2, pp. 99–106, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. A. M. do Nascimento, M. J. Salvador, R. C. Candido, I. Y. Ito, and D. C. R. de Oliveira, “Antimicrobial activity of extracts and some compounds from Calea platylepis,” Fitoterapia, vol. 75, no. 5, pp. 514–519, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. A. M. do Nascimento, M. J. Salvador, R. C. Candido, S. de Albuquerque, and D. C. R. de Oliveira, “Trypanocidal and antifungal activities of p-hydroxyacetophenone derivatives from Calea uniflora (Heliantheae, Asteraceae),” Journal of Pharmacy and Pharmacology, vol. 56, no. 5, pp. 663–669, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. V. L. S. Ribeiro, J. C. dos Santos, J. R. Martins et al., “Acaricidal properties of the essential oil and precocene II obtained from Calea serrata (Asteraceae) on the cattle tick Rhipicephalus (Boophilus) microplus (Acari: Ixodidae),” Veterinary Parasitology, vol. 179, no. 1–3, pp. 195–198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. G. M. Marchetti, K. A. Silva, A. N. Santos et al., “The anticancer activity of dichloromethane crude extract obtained from Calea pinnatifida,” Journal of Experimental Pharmacology, vol. 4, pp. 157–162, 2012. View at Publisher · View at Google Scholar
  51. N. Matsuura, M. Yamada, H. Suzuki et al., “Inhibition of preadipocyte differentiation by germacranolides from Calea urticifolia in 3T3-L1 cells,” Bioscience, Biotechnology and Biochemistry, vol. 69, no. 12, pp. 2470–2474, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Rivero, J. Quintana, J. L. Eiroa et al., “Potent induction of apoptosis by germacranolide sesquiterpene lactones on human myeloid leukemia cells,” European Journal of Pharmacology, vol. 482, no. 1–3, pp. 77–84, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Nakagawa, M. Iinuma, N. Matsuura et al., “A potent apoptosis-inducing activity of a sesquiterpene lactone, arucanolide, in HL60 cells: a crucial role of apoptosis-inducing factor,” Journal of Pharmacological Sciences, vol. 97, no. 2, pp. 242–252, 2005. View at Publisher · View at Google Scholar · View at Scopus